U.S. FDA approves Bayer’s Xarelto® for patients with coronary or peripheral artery disease

Xarelto, in combination with aspirin, is indicated to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease ...

Vote for your favorite social impact pioneers

The international awards from the Bayer Foundations honor groundbreaking solutions to humanity’s biggest challenges in health and nutrition ...

Bayer to showcase latest oncology research at ESMO 2018 Congress

Research presented includes expanded pivotal trial data set on larotrectinib in development for TRK fusion cancer ...

Bayer encourages Argentine farmers to a sustainable soybean production

Signficance of canine leishmaniosis highlighted at leading dermatology congress

Bayer is a leading sponsor of the 30th European College of Veterinary Dermatology (ECVD) Congress / Cutaneous lesions are the most common finding in cases of canine leishmaniosis and awareness of the clinical signs is vital for all veterinarians / The congress marks the launch of Seresto’s new indication to reduce the risk of infection with Leishmania infantum in dogs for up-to eight months ...

Bayer partners with Genedata to digitalize Crop Science Research and Development

Bayer statement on glyphosate and honey bee health

Bayer receives positive CHMP opinion for its hemophilia A treatment BAY94-9027

The safety and efficacy profile of BAY94-9027 has been demonstrated in more than five years of clinical studies / Prophylaxis with BAY94-9027 enables sustained factor VIII concentrations in the blood over time ...

Bayer’s Jivi® approved in Japan for hemophilia A

Bayer announces Care4Cattle grant recipients in celebration of advancing cattle well-being

Three projects to receive Care4Cattle grants for innovations in advancing the well-being of cattle / Care4Cattle received over 100 entries across 37 countries, with winners selected from Australia, Brazil and the United Kingdom ...